| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |